By Jobee Knight

Calcium and magnesium have long been major players in the quest for achieving vibrant health. The pioneering nutritionist Adelle Davis says: “Calcium can be as soothing as a mother, as relaxing as a sedative, and as life-saving as an oxygen tent.” And James F. Balch, M.D., author of Prescription for Nutritional Healing says: “Supplementing with magnesium helps prevent irritability, nervousness, muscle weakness, high blood pressure, and heart disease.”

Nutrition-smart consumers should know the correct way to balance calcium and magnesium when taking supplements and be aware that the two act together as a synergistic team. Deficiencies of these minerals can contribute to nervous tension, an inability to relax, and insomnia. Dr. Balch says: “A lack of the nutrients calcium and magnesium will cause you to wake up after a few hours and not be able to return to sleep.” Read the rest of this entry

Philips Respironics and ResMed Inc. are joined by Cephalon Inc. to fund second year of Continuing Medical Education program

SleepApneaDisorder/[Press Release]/Murrysville, Pa., San Diego, Ca., and Frazer, Pa. USA – Philips Respironics, a unit of Royal Philips Electronics (NYSE: PHG, AEX: PHI), ResMed Inc. (NYSE: RMD and ASX: RMD.AX), and biopharmaceutical company, Cephalon Inc. (NASDAQ: CEPH), are supporting efforts  to bring untreated sleep apnea to the forefront of discussion among primary care physicians (PCP). As the program enters its second year, Cephalon joins the device makers in responding to educational grant requests to fund a series of independent continuing medical education (CME) activities on this important topic.
“We are committed to lending our support to the sleep community to further awareness and physician understanding of the medical consequences of untreated sleep apnea,” explains Eoghan O’Lionaird, General Manager-Sleep for Philips Respironics. “CME programs are a critical component in bridging the gap for this growing public health issue.” Read the rest of this entry

New Snore Pillow Released

SleepApneaDisorder/[Press Release]/Oct 03, 2010/ – Thanks to the latest advancements of a greater sleep technology that created Snore Pillow, you will no longer have to listen to your companion snoring logs any longer. Or, they will no longer have to listen to yours. By using an anti Snore Pillow, the one who breathes noisily while sleeping generally will stop snoring altogether, or experience a decrease in the severeness on their snoring. This is Enough to help both partners to obtain a good night rest. Read the rest of this entry

Obstructive sleep apnea (OSA) is associated with an increased risk of motor vehicle crash.

Researchers performed a systematic review of the literature concerning the impact of continuous positive airway pressure (CPAP) treatment on motor vehicle crash risk among drivers with OSA. The primary objective was to determine whether CPAP use could reduce the risk of motor vehicle crash among drivers with OSA. A secondary objective involved determining the time on treatment required for CPAP to improve driver safety.

Data Sources for the researchers for this study included seven electronic databases (MEDLINE, PubMed (PreMEDLINE), EMBASE, PsycINFO, CINAHL, TRIS, and the Cochrane library) and the reference lists of all obtained articles. Read the rest of this entry

Sleep Apnea-Symptoms-Types-Risks-Snoring-Treatment

Sleep apnea is a sleep disorder is defined by brief interruptions of breathing while you are asleep. This is a very serious condition, because it can result in high blood pressure, heart problems and stroke.

Signs and Symptoms of Sleep Apnea

The warning signs and symptoms of sleep apnea include: Read the rest of this entry

Phelps Memorial Hospital Center’s Healthy Life series continues to offer the community a wide range of programs on health-related subjects, as well as numerous health screenings and support groups.
All events take place on the Phelps campus, 701 North Broadway in Sleepy Hollow, unless otherwise noted.

On Tuesday, October 5, 2010 Better Breathers Club will be holding an informative discussion about sleep apnea and its effects on those with lung disease. Light refreshments will be served.

Contact Michael Bergstein, MD, otolaryngologist. 6-7pm. Pulmonary Lab Gym. Call (914) 366-3712 to register.

Greek Population:Prediction of Obstructive Sleep Apnea

In a recently concluded research the investigators aimed to evaluate the predictive value of anthropometric measurements and self-reported symptoms of obstructive sleep apnea syndrome (OSAS) in a large number of not yet diagnosed or treated patients. Commonly used clinical indices were used to derive a prediction formula that could identify patients at low and high risk for OSAS.

Two thousand six hundred ninety patients with suspected OSAS were enrolled.Researchers obtained weight; height; neck, waist, and hip circumference; and a measure of subjective sleepiness (Epworth sleepiness scale-ESS) prior to diagnostic polysomnography. Excessive daytime sleepiness severity (EDS) was coded as follows: 0 for ESS???3 (normal), 1 for ESS score 4-9 (normal to mild sleepiness), 2 for score 10-16 (moderate to severe sleepiness), and 3 for score >16 (severe sleepiness). Multivariate linear and logistic regression analysis was used to identify independent predictors of apnea-hypopnea index (AHI) and derive a prediction formula. Read the rest of this entry

Patients implanted with the ImThera aura6000 hypoglossal nerve neurostimulation device for treating obstructive sleep apnea (OSA) showed a reduced apnea/hypopnea index (AHI) and improvements in oxygen desaturation index (ODI), according to information released by ImThera.

For the study, 10 patients have been surgically implanted with the device. The target population for ImThera’s neurostimulation device, which is not available in the United States, is moderate and severe OSA patients who are noncompliant with or cannot tolerate continuous positive airway pressure (CPAP). Read the rest of this entry

Research and Markets has announced the addition of the “Australia Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015” report to their offering.

This report provides critical market data on the patient monitoring and diagnostics sector in Australia. It includes key market categories- such as wireless hospital ambulatory monitors, multiparameter patient monitors, remote monitoring systems, blood pressure monitors, micro-electromechanical systems, cardiovascular monitoring systems, sleep apnea diagnostic systems, hearing diagnostics and glucose monitoring devices. Read the rest of this entry

Sleep Apnea Surgery Needs Practice Standardization

In 2006, an estimated 35,263 surgeries for sleep apnea were performed in inpatient and outpatient settings in the United States, including 33,087 palate, 6,561 hypopharyngeal, and 1,378 maxillomandibular advancement procedures. Compared to hypopharyngeal surgery, the odds of undergoing isolated palate surgery were higher for younger (age 18-39 years) and black patients, but were not associated with other variables.

In a presentation at the 2010 AAO-HNSF Annual Meeting & OTO EXPO in Boston, researchers revealed that only 0.2 percent of all adults with OSA annually, as OSA surgery is common and costly. Variations in cost and procedure type related to selected patient and hospital factors provide a potential opportunity for practice standardization.

Related Posts with Thumbnails